Increasing expenditure on research and development by
pharmaceutical and biotech companies will also contribute to the growth of the
market. A label free detection method is used to detect biomolecules and their
interactions. This method has emerged as an attractive research and development
tool in the pharmaceutical and biotech industry. Partnerships between pharmaceutical
companies and academic institutions and increasing number of drug discovery
programs will drive the market growth.
Explore More Insights@ https://www.alliedmarketresearch.com/request-toc-and-sample/556
Major Types & Applications
Present in Label Free Detection Market as followed:
By Technology
· Cellular Dielectric
Spectroscopy
· Bio-layer
Interferometry
· Surface Plasmon
Resonance
· Optical Waveguide
Grating Technology
By Type
· Instruments
· Consumables
· Biosensor chips
· Microplates
By Application
· Contract Research
Organizations (CRO)
· Pharmaceutical and
Biotechnology Companies
· Academic Research
Institutes
Key Benefits
·
The report throws light on the dominant current
trends. Based on the analysis of trends, revenues are forecast from 2013–2020.
·
Analysis of key strategies adopted by market
players would assist in providing an in-depth understanding of market
intelligence.
·
Analysis of trends in various regions would help
companies to plan their strategies depending on the region.
·
Drivers and opportunities are evaluated to
highlight the top factors responsible for market growth. Various segments are
carefully evaluated to gauge the potential of the market.
·
Porter’s Five Forces analysis provides an
insight into market dynamics and industry competition.
The label free detection
market is segmented into technology, product, application, end user, and
geography. On the basis of technology, the market is segmented into cellular
dielectric spectroscopy, bio-layer interferometry, surface plasmon resonance,
optical waveguide grating technology, and others.
The consumables segment
is further divided into biosensor chips and microplates. The application market
is segmented into binding thermodynamics, binding kinetics, hit confirmation,
lead generation, endogenous receptor detection and others. The label free
detection end user market comprises contract research organizations (CRO),
pharmaceutical and biotechnology companies, academic research institutes and
others. Geographically, the market is segmented into North America, Europe,
Asia-Pacific and LAMEA.
Some of the players in
the market are Bio-Rad Laboratories, General Electric, Bioptics, Atana,
Ametech, Inc., Corning, Inc., Pal Corporation, Danaher Corporation, X-Body
Bioscience, and Roche Diagnostics.
0 Comments